Cadrenal Therapeutics Stock Forecast

Sell candidate since May 08, 2026 Loss -31.20%

The Cadrenal Therapeutics, Inc. stock price fell by -3.68% on the last day (Wednesday, 3rd Jun 2026) from $4.35 to $4.19. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 5.76% from a day low at $4.17 to a day high of $4.41. The price has fallen in 5 of the last 10 days and is down by -15.69% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -110 thousand shares and in total, 45 thousand shares were bought and sold for approximately $190.55 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.29% during the next 3 months and, with a 90% probability hold a price between $1.87 and $4.18 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CVKD Signals & Forecast

There are few to no technical positive signals at the moment. The Cadrenal Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.76 and $5.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 30, 2026, and so far it has fallen -37.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cadrenal Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.240 between high and low, or 5.76%. For the last week the stock has had daily average volatility of 7.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CVKD) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Cadrenal Therapeutics, Inc. to open at $4.26, and during the day (based on 14 day Average True Range), to move between $3.94 and $4.44, which gives a possible trading interval of +/-$0.500 (+/-12.70%) up or down from last closing price. If Cadrenal Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.70% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.35, some $0.160 (3.82%) from the current price of $4.19, our system finds the risk reward not very attractive.

Is Cadrenal Therapeutics, Inc. stock A Buy?

Cadrenal Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.990 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $4.26 ( 1.59%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk